Bulletin board
Pharmacy Permit Renewals Due by November 1
Pharmacy managers must submit the online Pharmacy Permit Application for Renewal and fees; and meet the requirements of SCPP legislation no later than November 1, 2019. more
[directions] Newsletter Oct 2019
The October edition of [directions], specific to the COMPASS program and medication and patient safety, is now available. Click here to download the most recent edition.
Doctor’s Licence Suspensions
Dr. El-fellani Mohammed’s (Regina) licence has been suspended from October 13, 2019 to January 12, 2020. Effective October 14, 2019, Dr. Alfred Ernst’s (Rosetown) licence is suspended for two months. The complete penalty decisions will be posted on the College of Physicians and Surgeons of Saskatchewan’s website later this week. Please refer to SCPP’s Prescription Validity document regarding new prescriptions or refills in these situations.
Health Canada Advisory - Ranitidine
Health Canada is advising Canadians that it is aware that the impurity N-nitrosodimethylamine (NDMA) has been detected in some ranitidine drugs. NDMA is classified as a probable human carcinogen, which means long-term exposure to levels above what is considered safe could increase the risk of cancer. Health Canada is working to better understand the issue and whether there may be a risk to Canadians. more
We have moved!
Effective Sept 1/19 our new address is 100-1964 Park St. Regina, SK S4N 7M5. All phone/fax and email addresses remain the same.
Dr. M. Davis of Kamsack Resigned July 18, 2019
Dr. Murray Davis has resigned as a member of College of Physicians and Surgeons of Saskatchewan (CPSS) effective July 18, 2019. more
Prescribing Privileges for SK Podiatrists
Saskatchewan podiatrists recently received legislated authority to prescribe certain categories of medications. more
Dr. N. Maree prohibited from prescribing PRP
Dr. Narinda Maree will be practising under supervision and is prohibited from prescribing PRP medications more
Urgent Notice - Dr. Moolla Methadone Patients
Guidance for interim supply of methadone and buprenorphine/naloxone – Dr. H. Moolla more
Dr. Fern has Returned to Practice
As of May 23, 2019, Dr. Fern has returned to practice, resumed treating and prescribing Opioid Agonist Therapy for his patients more
Pharmacy Suspension Notice: Dewdney Drugs (1986) Ltd. – UPDATE
Resulting from the closure of Dewdney Drugs (1986) Ltd., it has become necessary for patients, NHIB clients, pharmacists more
Suspension - Dewdney Drugs (Regina)
Please be advised that SCPP has suspended the permit of Dewdney Drugs (1986) Ltd. until further notice as of 4:00 p.m. Thursday May 2, 2019, in accordance with The Pharmacy and Pharmacy Disciplines Act, SS 1996, c P-9.1 more
Communication to Members - Dr. Paul and Dr. R. Patel Methadone Patients
Saskatchewan will be the first province in Canada to be provided with an exemption 56 to provide more
AUTHUR WOO LICENCE SUSPENSION
Please be advised that SCPP has suspended the license to practice pharmacy for member Arthur Woo (D1971) until further notice, in accordance with The Pharmacy and Pharmacy Disciplines Act, SS 1996, c P-9.1 more
Changes to Mifegymiso Ultrasound no longer required
Health Canada is informing Canadians that the prescribing and patient information for Mifegymiso has been updated more
Health Canada Drug Recall
Multiple Losartan-containing drugs voluntarily recalled because of potential for nitrosamine impurity
Health Canada is advising Canadians that multiple lots of Losartan-containing drugs are being voluntarily recalled by Teva Canada, Apotex Inc., Pharmascience Inc., and Pro Doc Limitée because of the potential for a nitrosamine impurity, N-Nitroso-N-methyl-4-aminobutyric acid (NMBA). NMBA is potentially a human carcinogen, which means that long-term exposure could increase the potential risk of cancer. more
Health Canada is advising Canadians that multiple lots of Losartan-containing drugs are being voluntarily recalled by Teva Canada, Apotex Inc., Pharmascience Inc., and Pro Doc Limitée because of the potential for a nitrosamine impurity, N-Nitroso-N-methyl-4-aminobutyric acid (NMBA). NMBA is potentially a human carcinogen, which means that long-term exposure could increase the potential risk of cancer. more
2019 Wellspring Leadership Award
The Canadian Foundation for Pharmacy is pleased to announce the 2019 Wellspring Pharmacy Leadership Award Program more
Regulatory Bylaw Certificate - Methadone
Approval of the Registrar of the College of Physicians and Surgeons (CPSS) is not required when prescribing methadone for pain. There are also other exemptions more
TEMPORARY LICENCE SUSPENSION
Please be advised that SCPP has temporarily suspended the license to practice pharmacy for member Jennifer Yaholnistky (D4587) pending investigation of professional misconduct, in accordance with The Pharmacy and Pharmacy Disciplines Act, SS 1996, c P-9.1
Sask. Polytechnic SPTA Course
Saskatchewan Polytechnic is now accepting registrations for the Structured Practical Training and Assessment (SPTA) course Course listing
DRUG SHORTAGE - ELLA™
ella™ (ulipristal acetate) is an oral emergency contraceptive product. McKesson has identified a shortage until about December 7
New number to call for people seeking info about MAID
People seeking medically assisted death can now call the provincial 811 health line (CBC news)
OPIOID STICKERS AND PATIENT HANDOUT REQUIREMENTS
Mandatory Opioid Warning Sticker and Patient Information Handout
Health Canada announced "Regulations Amending the Food and Drug Regulations" on opioids that will alter the current opioid dispensing workflow of pharmacists more
Zhejiang Huahai Pharmaceuticals site non-compliant
Health Canada finds Zhejiang Huahai Pharmaceuticals site non-compliant with requirements for the manufacture of drug ingredients. No products are being recalled at this time more
Influenza Immunization Program
CONTINUING PROFESSIONAL DEVELOPMENT FOR PHARMACY PROFESSIONALS (CPDPP)
Find CE Online Courses and Live Events: www.usask.ca/cpdpp
Regulatory Updates
EXEMPTION 56 - METHADONE
Subsection 56(1) Class Exemption expires on September 30, 2019. Exemption info MicroSCOPe article..
EPIPEN® BACK ON SCHEDULE I
At the December meeting, Council decided not to extend the temporary bylaw that came into effect on August 27, 2018, which moved epinephrine ampoules from Schedule I to Schedule II for the treatment of anaphylaxis due to allergens. Therefore, effective December 31, 2018, epinephrine ampoules for anaphylaxis are no longer Schedule II and are back on Schedule I status...
Naloxone Unscheduled
Saskatchewan becomes the third province to move naloxone to unscheduled status more..
REGULATORY BYLAW REPEALED
Effective March 16, 2018, Part N, section 11(2) of the SCPP Regulatory Bylaws was repealed (linked document updated March 22) more..
MIFEGYMISO PRESCRIBING AND DISPENSING UPDATE
Please review the November 7, 2017, Health Canada updates to prescribing and dispensing information for Mifegymiso® here ..
CQI BYLAWS APPROVED
The Minister of Health has approved the bylaws that set the Continuous Quality Improvement (CQI) program requirement, which will be met by COMPASS starting with the 2017-2018 permit year. The new bylaws can be found in Section 12 of Part I in the SCPP Regulatory Bylaws. more ..
MINOXIDIL NOW UNSCHEDULED
Effective July 20, 2017, topical minoxidil, in concentrations of 5% or less, is now an unscheduled product and may be sold from any retail outlet (including online) more ..
Events
Nov
16
Vaccine Preventable Disease and Low-Risk Travel Health Prescribing Guideline and Implementation Training - Saskatoon
Nov 16 in Saskatoon and Nov 17 in Regina. CPDPP training focuses on the process for implementing vaccine prescribing or travel health services. more
Nov
16
Heart Disease & Stroke 2019
Nov 16 & 17 in Saskatoon. Topics include: thrombolysis in MI and stroke, cardiac and stroke rehab, as well as risk stratification and management in Afib: watchman data. more
Nov
17
Vaccine Preventable Disease and Low-Risk Travel Health Prescribing Guideline and Implementation Training - Regina
Nov 17 in Regina. CPDPP training focuses on the process for implementing vaccine prescribing or travel health services. more
Nov
20
CFP Pharmacy Forum
Nov 20 in Toronto. Hear from industry leaders as they explore CFP's vision for the future of pharmacy. more
Nov
30
SEMAC XI 2019
Nov 30 in Saskatoon. Topics include: opioid crisis, geriatric emergency medicine, and rheumatology. As well as, delivering a one of a kind interactive medical escape room! more